Cancelling your registration will remove your access to the event. If you proceed, you will no longer be able to participate or access event-related materials.
Deleting your account will remove your access to the event.
We're getting ready to share with you this year's speakers!
Head of Innovation Promotion and Internationalisation
Ana Isabel González-González, MD, PhD, is Head of Innovation Promotion and Internationalisation of Health Research at the Directorate-General for Research and Teaching of the Regional Ministry of Health of Madrid. She is also the EIT Health Master Contact for the Madrid Health Service (SERMAS) and its Legal Entity Appointed Representative (LEAR) for Horizon Europe.
A family physician and senior researcher, she has extensive experience in European collaborative research, health services research and innovation. Her work focuses on strengthening the participation of the Madrid health system in European programmes, fostering public–private collaboration and supporting the development and implementation of innovative solutions.
Her areas of interest include health data, digital transformation, value-based healthcare, multimorbidity and medication management, with a strong focus on translating research and innovation into meaningful impact for healthcare systems and patients.
Public Health Innovation Lead
Dr Moredreck Chibi is an international public health innovation expert currently leading strategic innovation initiatives at the WHO Regional Office for Europe. He has coordinated the development of the region’s Strategy for Harnessing Innovation for Public Health 2025–2030, as well as its regional innovation agenda.
Previously, he served as Regional Focal Point for Science and Innovation at the WHO Regional Office for Africa, where he contributed to Africa’s first regional strategy for scaling health innovations and chaired a UN coalition advancing the Sustainable Development Goals through science and digital transformation.
With more than 20 years of experience across WHO regional offices and headquarters, his work focuses on scaling health innovation, strengthening innovation ecosystems and fostering international collaboration. He holds a PhD in Medical Biosciences, an Executive MBA in Innovation Management and an MPH from Imperial College London.
Chief Executive Officer & Co-founder
Alfons Carnicero is an entrepreneur from Barcelona focused on using technology to improve the quality of life of people with disabilities. He holds a Master’s degree in Industrial Engineering, specialising in Biomedical Engineering, from the Universitat Politècnica de Catalunya, as well as executive training in entrepreneurship from Cambridge Judge Business School, EADA and ISDI.
His career began at Implantcast GmbH, a joint implant manufacturer, and Institut Guttmann, a neurorehabilitation hospital. In 2018, he co-founded ABLE Human Motion, a healthcare start-up working to make exoskeleton technology more accessible.
Alfons has been recognised as an Innovator Under 35 Europe by MIT Technology Review and as a “Joven Relevante” by Círculo Ecuestre. He also serves on the Steering Committee of the International Industry Society for Advanced Rehabilitation Technology (IISART).
Simulation and Educational Innovation Specialist
Bruno Miguel Silva is a physician working in Medical Oncology and an invited faculty member at NOVA Medical School in Lisbon. His work focuses on cancer survivorship, personalised medicine, medical education and simulation-based training.
He leads the GENCareSim consortium, an EP PerMed-funded project focused on simulation-based education for hereditary cancer survivorship. His work also includes the implementation of clinical pathways and digital solutions in cancer survivorship, with particular emphasis on integrating patient-reported outcomes and personalised supportive care into clinical practice.
Director
Sofía Moreno-Pérez is a Telecommunications Engineer and Executive MBA graduate who has served as Director of VALDE Innova since 2008. She specialises in Innovation Procurement, bringing a practical, demand-side perspective to the design and implementation of innovative public procurement processes.
She has more than ten years of experience in the field, including roles in the STOPandGO and award-winning RITMOCORE projects, and has coordinated procurer activities in the PCP projects ROSIA, TIQUE and CRANE.
Until recently, she was a partner and Innovation Procurement Expert at HIPPS, where she contributed to the development of support services for health-sector procurers and innovation providers. Her work focuses on aligning buyer needs with innovative solutions and strengthening the capacity of public organisations to adopt innovation effectively.
Principal
Secretary General for Innovation
Teresa Riesgo has served as Secretary General for Innovation at the Spanish Ministry of Science, Innovation and Universities, as well as President of the Center for Technological Development and Innovation (CDTI), since January 2020. She previously held the position of Director General for Research, Development and Innovation from July 2018. She holds a Master's degree and a PhD in Industrial Engineering from the Technical University of Madrid (UPM), where she is Full Professor of Electronics since 2003. Throughout her academic career, she has
participated in more than 60 research projects—many of them international and in collaboration with industry—and has published over 200 scientific documents.
With more than 25 years of experience in academia, research, and innovation, she assumed the role of Director General at the Ministry, where she is currently responsible for innovation policies in both the private and public sectors, as well as for promoting entrepreneurship in deep tech and advanced technologies.
_1790580668751.png)
CEO & Co-founder
Noora Hujala (Pharm, MSc, EMBA) is the CEO and Co-founder of Solid IO, a University of Helsinki spinout developing a functional precision medicine platform to help personalize cancer treatment. She brings nearly 30 years of experience across the healthcare ecosystem, spanning clinical work, commercial leadership, growth and business transformation. Driven by a mission to improve how patients are treated at scale, she co-founded Solid IO with her scientific co-founders to expand patient access to effective cancer treatments.
CEO & Co-founder
Biotech entrepreneur focused on bringing new medicines to patients and strengthening Europe’s biotech ecosystem. He co‑founded PhagoMed Biopharma and led it as Co‑CEO through its acquisition by BioNTech, where he then co‑led the Austrian R&D hub and brought new drug candidates into the clinic. Alexander is now building his new venture Sameric Bio to close Europe’s translation gap by advancing promising biology to clinical proof‑of‑concept. He also invests in early‑stage health and deep‑tech companies through LANA Ventures and mentors life science ventures via the Creative Destruction Lab.
CEO
Cornel Amariei is a renowned Romanian inventor, speaker and entrepreneur known for creating .lumen, the startup that builds Glasses which empower the blind to live a better life.
Cornel was born into a family where he was the only person without a disability, severely limiting their mobility. Growing up in such an environment allowed Cornel to understand the role of assistive technology.
Previously, Cornel was known for operating as Head of Innovation in a large Automotive company. For his work, he became the first Romanian inducted into Forbes 30U30 Europe, the Global Business Hall of Fame and JCI's Ten Outstanding Young Persons of the World, recognitions associated, over time, with figures such as John F. Kennedy, Elvis Presley, and Levi Strauss.
Registration process
Any queries regarding registration or payment should be sent to eithealthsummit@eithealth.eu
By registering for the EIT Health Summit, you confirm your intention to attend the event. Once your registration has been completed, the applicable participation fee must be paid in full via the event platform.
If you are unable to attend the EIT Health Summit, you may cancel your registration at any time.
All cancellations must be submitted by email to eithealthsummit@eithealth.eu and must include your first name, surname, email address and telephone number. Please ensure that the name and email address provided correspond to the details used for your Summit registration.
The following cancellation and refund conditions apply:
The participant may provide evidence that EIT Health incurred lower costs in connection with the participant's registration than the amount retained. In such circumstances, or where there are other valid reasons supporting a higher refund, the participant may request an adjustment of the refund amount.
EIT Health reserves the right to cancel, postpone or modify the EIT Health Summit, including the date, venue, programme or individual sessions, where this is reasonably necessary due to circumstances beyond EIT Health's reasonable control.
In the event that EIT Health cancels the Summit in its entirety, participants will be entitled to a refund of the participation fee paid.
Where the Summit is postponed, the registration may, at EIT Health's discretion, be transferred to the rescheduled event. Participants who are unable to attend the rescheduled event may request a refund of the participation fee paid.
EIT Health will communicate any cancellation or postponement to registered participants as soon as reasonably practicable.
EIT Health shall not be liable for any additional costs or expenses incurred by participants in connection with the cancellation, postponement or modification of the Summit, including travel, accommodation or other related expenses, except where otherwise required by applicable law.
EIT Health reserves the right to make reasonable changes to the programme, speakers, schedule, venue or other organisational arrangements where necessary.
Such changes will not, in themselves, give rise to a right to a refund, provided that the Summit continues to take place substantially as planned.
Where a refund is due under these terms and conditions, it will be processed using the payment method originally used for the registration, unless otherwise agreed with EIT Health.
Any applicable processing or transaction fees may be deducted from the refund were permitted by applicable law.
The contract between EIT Health and the participant shall be governed by the laws of the Federal Republic of Germany, subject to mandatory provisions of international private law. The United Nations Convention on Contracts for the International Sale of Goods (CISG) shall not apply.